Sfoglia per AUTORE
CERRI M
Collezione AOU Novara

  

Items : 2

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.

2015
AOU Città della Salute di Torino
AOU Novara

Zinzani PL; Massaia M; Moreno C; Del Poeta G; Perbellini O; Marasca R; Neri A; Tedeschi A; Rigolin GM; Motta M; Coscia M; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Cortelezzi A; Mauro FR; Morabito F; Visco C; Bulian P; Chiarenza A; Ghilardi G; Cerri M; De Paoli L; Terzi-di-Bergamo L; Rossi D; Montillo M; et alii...

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2009 Feb 1;15(3):995-1004. doi: 10.1158/1078-0432.CCR-08-1630.

2009
AOU Novara

Rossi D; Cerri M; Deambrogi C; Sozzi E; Cresta S; Rasi S; De Paoli L; Spina V; Gattei V; Capello D; Forconi F; Lauria F; Gaidano G;